This document reports on global progress toward universal access to HIV/AIDS prevention, treatment, and care. Some key points: - An estimated 34 million people were living with HIV globally in 2010, with sub-Saharan Africa the most affected region at 22.9 million. - New HIV infections and AIDS-related deaths declined between 2001 and 2010, but progress needs to accelerate to achieve international targets. - The number of people receiving antiretroviral therapy has increased substantially in low- and middle-income countries, reaching 6.65 million by the end of 2010, but coverage remains inadequate in many areas. - Preventing mother-to-child transmission has expanded significantly, but more work

1. GLOBAL HIV/AIDS RESPONSE
Epidemic update and
health sector progress
towards Universal Access
Progress Report 2011

2. Adults and children estimated to be living with HIV,
by WHO Region, 2010
Europe
2.3 million
[2.1 million – 2.5 million]
Americas
3.0 million
[2.6 million – 3.5 million]
South-East Asia
Eastern
Mediterranean
3.5 million
[3.0 million – 3.9 million]
560 000
[410 000 – 790 000]
Africa
Western Pacific
[21.7 million – 24.2 million]
[1.1 million – 1.5 million]
22.9 million
1.3 million
Total: 34.0 million [31.6 million – 35.2 million]

3. Estimated number of adults and children newly infected with HIV,
by WHO Region, 2010
Europe
190 000
[150 000 – 230 000]
Americas
170 000
[120 000 – 240 000]
South-East Asia
Eastern
Mediterranean
210 000
[180 000 – 260 000]
82 000
[54 000 – 130 000]
Africa
1.9 million
[1.7 million – 2.1 million]
Western Pacific
130 000
[88 000 – 190 000]
Total: 2.7 million [2.4 million – 2.9 million]

4. Estimated adult and child deaths from AIDS,
by WHO Region, 2010
Europe
99 000
Americas
96 000
[71 000 – 120 000]
South-East Asia
230 000
[84 000 – 120 000]
[190 000 – 260 000]
Eastern
Mediterranean
38 000
[27 000 – 53 000]
Africa
1.2 million
[1.1 million – 1.4 million]
Western Pacific
80 000
[64 000 – 99 000]
Total: 1.8 million [1.6 million – 1.9 million]

5. Children (<15 years) estimated to be living with HIV,
by WHO Region, 2010
Europe
19 000
Americas
58 000
[44 000 – 74 000]
South-East Asia
[15 000 – 25 000]
Eastern
Mediterranean
140 000
[92 000 – 190 000]
42 000
[28 000 – 57 000]
Africa
3.1 million
[2.8 million – 3.5 million]
Western Pacific
39 000
[33 000 – 46 000]
Total: 3.4 million [3.0 million – 3.8 million]

6. Estimated number of children (<15 years) newly infected with,
by WHO Region, 2010
Europe
2 400
South-East Asia
[1 900 – 2 900]
Americas
5 000
[3 200 – 6 900]
Eastern
Mediterranean
17 000
[11 000 – 25 000]
7 400
[5 200 – 9 800]
Africa
350 000
[300 000 – 410 000]
Western Pacific
5 000
[3 800 – 6 200]
Total: 390 000 [340 000 – 450 000]

7. Estimated deaths in children (<15 years) from AIDS,
by WHO Region, 2010
Europe
1 300
South-East Asia
[<1 000 – 1 800]
Americas
3 600
[2 100 – 5 100]
Eastern
Mediterranean
12 000
[6 800 – 18 000]
4 100
[2 800 – 5 500]
Africa
230 000
[200 000 – 260 000]
Western Pacific
2 700
[2 200 – 3 400]
Total: 250 000 [220 000 – 290 000]

8. Adult HIV prevalence (15–49 years),
by WHO Region, 2010
Europe
0.4%
[0.4 – 0.5%]
Americas
0.5%
[0.4 – 0.6%]
South-East Asia
0.3%
[0.3 – 0.3%]
Eastern
Mediterranean
0.2%
[0.1 – 0.3%]
Africa
Western Pacific
4.7%
[4.5 – 4.9%]
Total: 0.8% [0.8 – 0.8%]
0.1%
[<0.1 – 1%]

9. Percentage of women and men who received an HIV test and test
results in the 12 months preceding the survey in countries with
repeat population surveys, 2003–2010

10. Number of people receiving antiretroviral therapy in low- and
middle-income countries, by region, 2002–2010

11. Number of people (all age groups) receiving and needing
antiretroviral therapy, and percentage coverage in low- and
middle-income countries by region, 2009 to 2010

12. Low- and middle-income countries with estimated antiretroviral
therapy coverage levels of 50–69%, 70–79% and
80% or higher as of December 2010

13. Comparison of number of men and women receiving and estimated
to need antiretroviral therapy and percentage coverage, by region,
December 2010a

14. Number of children 0–14 years old and adults on antiretroviral
therapy in low- and middle-income countries, by region,
December 2010a

15. Retention rates for antiretroviral therapy at 12, 24 and 60 months
for selected countries

16. Adoption of the preferred medicine in first-line antiretroviral
regimens into national antiretroviral therapy guidelines, in reporting
low- and middle-income countries, 2010–2011
Not a preferred medicine in first-line antiretroviral regimens according to 2010 WHO recommendations.
a

17. Monitoring Framework of the Global Plan towards the elimination of new HIV
infections among children by 2015 and keeping their mothers alive
TARGETS AND INDICATORS
Source: Countdown to zero: Global Plan towards the elimination of new
HIV infections among children by 2015 and keeping their mothers alive
2011–2015.

18. Estimated number of children newly infected with HIV in low- and
middle-income countries, 2000–2015

19. Syphilis seropositivity of women attending antenatal care reported
by countries in 2010

20. Percentage of pregnant women who received an HIV test in the
past 12 months in low- and middle-income countries by
region, 2005 and 2008–2010

21. Coverage of antiretroviral medicine for preventing mother-to-child
transmission: most effective regimens and single-dose
nevirapine, low- and middle-income countries, by region, 2010 a

22. Estimated number of women living with HIV needing and receiving
antiretroviral medicine for PMTCT in low- and middle-income
countries, 2010

23. Low- and middle-income countries achieving
≥80% coverage with effective regimens
of antiretroviral medicine for preventing mother-to-child
transmission, 2010

24. Countries with the largest contribution to the global gap in reaching
90% of pregnant women living with HIV in need with antiretroviral
medicine for preventing mother-to-child transmission, 2010

25. % of pregnant women living with HIV and their infants who received
antiretroviral medicine for preventing mother-to-child transmission,
low- and middle-income countries, 2005–2010

26. Percentage of children living with HIV receiving antiretroviral therapy
in low- and middle-income countries, 2005, 2009 and 2010